Company: Sysmex Inostics
Job title: Vice President, Commercial Operations
Dan Edelstein, M.S., MBA is VP of Commercial Operations at Sysmex Inostics. He previously studied at Johns Hopkins and worked on early clinical studies of circulating tumor DNA. At Hopkins, he described novel genotype-phenotype relationships and diagnostic approaches for hereditary cancer syndromes. In 2011, Dan led the development of a CLIA laboratory for BEAMing-based (enhanced digital PCR) ctDNA analyses, delivering the first commercial ctDNA assay for clinical practice and prospective clinical trials. Since then, he has worked on clinical utility evidence development and novel reimbursement pathways for ctDNA assays for the management of patients with cancer.